FibroGen Story Overview

FGEN -- USA Stock  

USD 57.45  0.65  1.14%

Macroaxis does not monitor all media channels or aggregates social signals for FibroGen. But even though we do not provide professional-grade financial sentiment analysis on FibroGen, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for FibroGen. Additionally see FibroGen Hype Analysis, FibroGen Correlation and FibroGen Performance.
Insider Selling FibroGen, Inc Director Sells 567000.00 in Stock
EcoR1 Capital LLC lifted its holdings in FibroGen by 3,674.1 percent in the second quarter. EcoR1 Capital LLC now owns 1,585,457 shares of the biopharmaceutical company stock valued at 51,210,000 after acquiring an additional 1,543,448 shares during the ... Traders Brace for Comeback of Volatility FibroGen, Inc. , Frontline Ltd ... - Post Analyst

Read More...   

Story Momentum

This media report from www.thelincolnianonline.com distributed on December 7, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 2.54% . The overall trading delta when the story was published against the current closing price is 31.49% .

Similar stores for FibroGen

a day ago at www.macroaxis.com 
Exercise or conversion by Thomas Neff of 10320 shares of FibroGen subject to Rule 16b-3
Macroaxis News
Filed transaction by Fibrogen Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
few days ago at http://www.nasdaq.com 
Exercise or conversion by Thomas Kearns of 6000 shares of FibroGen subject to Rule 16b-3
nasdaq News
Filed transaction by Fibrogen Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a week ago at http://xnewspress.com 
Fmr LLC Boosts Position in FibroGen Inc
news
XNewsPressFull coverage
over a week ago at www.macroaxis.com 
Exercise or conversion by K Yu of 5000 shares of FibroGen subject to Rule 16b-3
Macroaxis News
Filed transaction by Fibrogen Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over two weeks ago at http://pressoracle.com 
FibroGen Downgraded by Citigroup
news
PressOracleFull coverage
over two weeks ago at http://cardinalweekly.com 
EPS for AutoZone, Inc. Expected At 17.87 Ecor1 Capital Lowered Its Kindred Biosciences Position
news
The Cardinal Weekly Full coverage
over three weeks ago at http://baycityobserver.com 
Exercise or conversion by Toshinari Tamura of 12000 shares of FibroGen subject to Rule 16b-3
news
Filed transaction by Fibrogen Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three weeks ago at http://richlandstandard.com 
Sale by Thomas Neff of 918 shares of FibroGen
news
Filed transaction by Fibrogen Inc director. General open market or private sale of non-derivative or derivative security
over a month ago at http://pressoracle.com 
Exercise or conversion by Thomas Neff of 10320 shares of FibroGen subject to Rule 16b-3
news
Filed transaction by Fibrogen Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a month ago at http://www.thecoinguild.com 
Equity News Investors Focusing on Shares of FibroGen, Inc as Company Makes Headlines With ...
news
The Coin GuildFull coverage
over a month ago at www.macroaxis.com 
Sale by Jorma Routti of 3700 shares of FibroGen
Macroaxis News
Filed transaction by Fibrogen Inc director. General open market or private sale of non-derivative or derivative security
over two months ago at http://thewellesleysnews.com 
2 Stocks Remain Some Of The Top Stocks To Watch MasTec, Inc. , FibroGen, Inc.
news
Analyst JournalFull coverage
over three months ago at http://bangaloreweekly.com 
FibroGen Inc. CEO Sold 429763.26 in Shares
news
BangaloreWeeklyThomas B. Neff Sells 636 Shares of FibroGen Stock The Ledger GazetteBrokerages Set FibroGen PT at 66.67 Week HeraldFull coverage

Shares Outstanding

Shares Outstanding Comparative Analysis

  Shares Outstanding 
      FibroGen Comparables 
FibroGen is currently under evaluation in shares outstanding category among related companies. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.

Peers

FibroGen Related Equities

DNLI  3.52 %   
0%
71.0%
EARS  2.85 %   
0%
57.0%
DVAX  1.72 %   
0%
34.0%
NK  0.69 %   
0%
13.0%
DMPI  0.06 %   
1.0%
0%
DOVA  0.45 %   
9.0%
0%
CO  2.37 %   
47.0%
0%
DRNA  3.39 %   
68.0%
0%
EDGE  4.04 %   
81.0%
0%
ECYT  4.95 %   
100.0%
0%
Additionally see FibroGen Hype Analysis, FibroGen Correlation and FibroGen Performance. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com